Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3M Sell
87,699
-125
-0.1% -$14.6K 0.73% 34
2026
Q1
$10.6M Hold
87,824
0.77% 35
2025
Q4
$9.24M Sell
87,824
-35,140
-29% -$3.3M 0.65% 37
2025
Q3
$10.3M Sell
122,964
-19,600
-14% -$1.61M 0.75% 37
2025
Q2
$11.3M Sell
142,564
-24,627
-15% -$1.96M 0.84% 33
2025
Q1
$15M Sell
167,191
-10,174
-6% -$950K 1.18% 25
2024
Q4
$17.6M Buy
177,365
+1,382
+0.8% +$142K 1.29% 21
2024
Q3
$20M Sell
175,983
-7,060
-4% -$839K 1.47% 19
2024
Q2
$22.7M Sell
183,043
-1,725
-0.9% -$222K 1.72% 17
2024
Q1
$24.4M Sell
184,768
-845
-0.5% -$104K 1.86% 14
2023
Q4
$20.2M Sell
185,613
-2,355
-1% -$244K 1.65% 16
2023
Q3
$19.4M Sell
187,968
-380
-0.2% -$41K 1.73% 16
2023
Q2
$21.7M Sell
188,348
-4,611
-2% -$524K 1.87% 13
2023
Q1
$20.5M Sell
192,959
-600
-0.3% -$64.8K 1.86% 11
2022
Q4
$21.5M Buy
193,559
+3,300
+2% +$337K 2.02% 10
2022
Q3
$16.4M Sell
190,259
-3,964
-2% -$354K 1.61% 17
2022
Q2
$17.7M Sell
194,223
-5,631
-3% -$499K 1.59% 16
2022
Q1
$16.7M Sell
199,854
-1,590
-0.8% -$125K 1.24% 27
2021
Q4
$15.4M Sell
201,444
-1,195
-0.6% -$95.2K 1.09% 31
2021
Q3
$15.2M Sell
202,639
-26,440
-12% -$2.01M 1.18% 28
2021
Q2
$17.8M Sell
229,079
-22,744
-9% -$1.69M 1.37% 22
2021
Q1
$18.5M Sell
251,823
-2,473
-1% -$182K 1.53% 19
2020
Q4
$19.8M Sell
254,296
-11,178
-4% -$855K 1.72% 15
2020
Q3
$21M Sell
265,474
-1,495
-0.6% -$117K 1.98% 11
2020
Q2
$19.7M Sell
266,969
-681
-0.3% -$51.3K 2.03% 11
2020
Q1
$19.6M Sell
267,650
-289
-0.1% -$22.7K 2.39% 9
2019
Q4
$23.3M Sell
267,939
-1,169
-0.4% -$96K 2.28% 8
2019
Q3
$21.6M Sell
269,108
-5,790
-2% -$464K 2.29% 7
2019
Q2
$22M Sell
274,898
-4,813
-2% -$369K 2.33% 7
2019
Q1
$22.2M Sell
279,711
-4,973
-2% -$372K 2.35% 7
2018
Q4
$20.8M Sell
284,684
-3,390
-1% -$239K 2.52% 5
2018
Q3
$19.5M Sell
288,074
-4,832
-2% -$308K 1.93% 9
2018
Q2
$17M Buy
292,906
+1,382
+0.5% +$78K 1.79% 10
2018
Q1
$15.2M Sell
291,524
-3,565
-1% -$193K 1.67% 12
2017
Q4
$15.8M Sell
295,089
-5,606
-2% -$311K 1.67% 10
2017
Q3
$18.4M Sell
300,695
-8,182
-3% -$496K 2.05% 5
2017
Q2
$18.9M Sell
308,877
-1,991
-0.6% -$121K 2.16% 5
2017
Q1
$18.8M Sell
310,868
-7,281
-2% -$442K 2.16% 4
2016
Q4
$17.9M Sell
318,149
-594
-0.2% -$34.8K 2.11% 5
2016
Q3
$19M Sell
318,743
-1,546
-0.5% -$90.4K 2.23% 5
2016
Q2
$17.6M Sell
320,289
-4,956
-2% -$264K 2.11% 5
2016
Q1
$16.4M Sell
325,245
-2,908
-0.9% -$142K 2% 6
2015
Q4
$16.5M Sell
328,153
-576
-0.2% -$29K 1.99% 7
2015
Q3
$15.5M Sell
328,729
-6,913
-2% -$367K 1.9% 7
2015
Q2
$18.2M Sell
335,642
-16,795
-5% -$942K 2% 5
2015
Q1
$19.3M Sell
352,437
-222
-0.1% -$12.6K 2.01% 5
2014
Q4
$19.1M Sell
352,659
-2,261
-0.6% -$126K 1.93% 6
2014
Q3
$20.1M Buy
354,920
+12,768
+4% +$717K 1.98% 5
2014
Q2
$18.9M Sell
342,152
-218
-0.1% -$11.9K 1.9% 6
2014
Q1
$18.5M Sell
342,370
-10,634
-3% -$551K 2.01% 7
2013
Q4
$16.9M Sell
353,004
-652
-0.2% -$29.8K 1.82% 10
2013
Q3
$16.1M Sell
353,656
-5,034
-1% -$230K 1.87% 8
2013
Q2
$15.9M Buy
+358,690
New +$16M 1.92% 9

Other funds holding MRK

Neville Rodie & Shaw's MRK Position: Q2 2026 in Review

Neville Rodie & Shaw reduced its Merck (MRK) stake by 0.14% in Q2 2026, selling an estimated $14.6K and leaving 87,699 shares worth $11.3M. The position accounts for 0.73% of the portfolio, ranked #34.

Neville Rodie & Shaw first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $24.4M in Q1 2024. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Neville Rodie & Shaw held 87,699 shares of Merck worth $11.3M as of Q2 2026.
  • Neville Rodie & Shaw sold 125 Merck shares in Q2 2026, an estimated $14.6K.
  • Merck made up 0.73% of Neville Rodie & Shaw's portfolio in Q2 2026, its #34 holding.
  • Neville Rodie & Shaw first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Neville Rodie & Shaw's Merck position peaked at $24.4M in Q1 2024.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Neville Rodie & Shaw's 13F filing for Q2 2026, filed 6 Jul 2026.